| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/31/2007 | US20070122340 Necrosis avid tracer agent |
| 05/31/2007 | DE69133083C5 Behandlung und Vorbeugung von erhöhten Lyso-PAF-Spiegel mediierten mentalen Erkrankungen mit PAF-Antagonisten Treatment and prevention mediated by elevated lyso-PAF mirror mental disorders with PAF antagonists |
| 05/31/2007 | DE102005057040A1 Pharmazeutischer Wirkstoff zur Behandlung von Krankheiten die verursacht werden von Lassaviren oder Filoviren A pharmaceutical agent for the treatment of diseases caused by Lassa virus or Filoviruses |
| 05/31/2007 | CA2631017A1 Bisboron compounds for use as intracellular calcium concentration increase inhibitors |
| 05/31/2007 | CA2628476A1 Pharmaceutical for use in the treatment of ureterolithiasis |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/30/2007 | EP1790715A1 Method for stabilizing the antiallergic activity of lactic acid bacteria aganst high-temperature treatment, stabilized compositions, and food and drink |
| 05/30/2007 | EP1790687A2 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 05/30/2007 | EP1790655A2 Biologically active peptides |
| 05/30/2007 | EP1790652A1 Polycyclic guanine phosphodiesterase V inhibitors |
| 05/30/2007 | EP1790650A1 Novel substituted imidazole derivatives |
| 05/30/2007 | EP1790644A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/30/2007 | EP1790642A1 Biologically active methylene blue derivatives |
| 05/30/2007 | EP1790641A1 Triazole derivative or salt thereof |
| 05/30/2007 | EP1790639A1 Compound containing basic group and use thereof |
| 05/30/2007 | EP1790637A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 05/30/2007 | EP1790355A1 Propagation agent and propagation method for natural killer cell |
| 05/30/2007 | EP1790353A1 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 05/30/2007 | EP1790352A1 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 05/30/2007 | EP1790346A2 Use of bile acid or bile salt fatty acid conjugates |
| 05/30/2007 | EP1790340A2 Combination chemotherapy |
| 05/30/2007 | EP1790339A1 Composition for prevention of occurrence of cardiovascular event |
| 05/30/2007 | EP1790338A1 Therapeutic agent for keratoconjunctiva disorder |
| 05/30/2007 | EP1790223A1 Organ arrest, protection and preservation |
| 05/30/2007 | EP1789389A1 Piperidine compound and process for preparing the same |
| 05/30/2007 | EP1789033A2 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/30/2007 | EP1499577B1 2-(2,6-dichlorophenyl)-diarylimidazoles |
| 05/30/2007 | EP1496924A4 Treatment of gastroparesis |
| 05/30/2007 | EP1490505B1 Tryptophan aminotransferase, indole-3-pyruvate decarboxylase and indole-3-acetaldehyde oxidase as novel targets for herbicides |
| 05/30/2007 | EP1458672B1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha(ppar) |
| 05/30/2007 | EP1427706B1 Substituted pyrazolo compounds for the treatment of inflammation |
| 05/30/2007 | EP1392291B1 Tripeptidyl peptidase inhibitors |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1311663B1 Claudin polypeptides |
| 05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 05/30/2007 | EP1263723B1 Ningalin b analogs employable for reversing multidrug resistance |
| 05/30/2007 | EP1257537B1 Therapeutic morpholino-substituted compounds |
| 05/30/2007 | EP1180103B1 Renin inhibitors |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | EP1171165B1 Intramyocardial injection of autologous bone marrow |
| 05/30/2007 | EP1117667B1 BENZOTHIENO[3,2-c]PYRIDINES AS ALPHA2 ANTAGONISTS |
| 05/30/2007 | EP1019010B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | EP0819121B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 05/30/2007 | EP0726954B2 Cytokine antagonists |
| 05/30/2007 | CN1972955A Radiosensitizer |
| 05/30/2007 | CN1972936A Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure |
| 05/30/2007 | CN1972909A Thio-substituted arylmethanesulfinyl derivatives |
| 05/30/2007 | CN1972688A 4-phenylamino-quinazolin-6-yl-amides |
| 05/30/2007 | CN1970071A Preparation method of minipills of 'Xiao Chai Hu' |
| 05/30/2007 | CN1970005A Medicament for improving anoxia tolerance and use thereof |
| 05/30/2007 | CN1969962A Medicated wine for treating infantile malnutrition |
| 05/30/2007 | CN1318588C Osteoprotegerine |
| 05/30/2007 | CN1318435C Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 05/30/2007 | CN1318434C Mitochondrially targeted antioxidants |
| 05/30/2007 | CN1318421C Non-nucleoside reverse transcriptase inhibitors |
| 05/30/2007 | CN1318420C Dipyridodiazepinones as reverse transcriptase inhibitors |
| 05/30/2007 | CN1318416C Indazole amide compounds as 5-serotoninergic agents |
| 05/30/2007 | CN1318413C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/30/2007 | CN1318412C Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 05/30/2007 | CN1318409C Oxy-and amino-substituted tetrahydrofurl derivatives with antitumour activity |
| 05/30/2007 | CN1318406C New barbituric acid derivatives, processes for their production and pharmaceutical agent containing same |
| 05/30/2007 | CN1318404C Aryl ureas as kinase inhibitors |
| 05/30/2007 | CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
| 05/30/2007 | CN1318084C Neuroprotective peptides |
| 05/30/2007 | CN1318068C Tonic liquid and preparing process thereof |
| 05/30/2007 | CN1318031C Compositions containing benzoxazinone and nucleoside like materials |
| 05/30/2007 | CN1318029C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1, 2, 3-triazoles |
| 05/30/2007 | CN1318027C GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 05/30/2007 | CN1318020C Blood nourishing, brain refreshing orally disintegrating tablet and its preparation process |
| 05/29/2007 | WO2006034832A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 05/29/2007 | US7225083 Determination antagonist, moderators; three-dimensional models |
| 05/29/2007 | US7223882 Reacting 2-amido-alkoxycarbonyl-benzaldehyde compound with alkoxycarbonyl-phosphonate compound, in the presence of lithium hydroxide in an organic solvent, adding lithium hydroxide adding an acid to the solution to obtain triterpene derivative |
| 05/29/2007 | US7223867 Preparation of benzosuberonylpiperidine compounds |
| 05/29/2007 | US7223858 Truncated aggrecanase molecules |
| 05/29/2007 | US7223857 Chain-shortened polynucleotide and method for preparation thereof |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
| 05/29/2007 | US7223837 Anticancer prodrugs, enhance enzymatic activation rates |
| 05/29/2007 | US7223835 Cyclic peptide mimetic for treating cancer; anticarcinogenic agents |
| 05/29/2007 | US7223794 For example, 2-{[(1S)-2-amino-1-phenylethyl]oxy}-4-chloro-5-fluorobenzonitrile; use in treatment or prophylaxis of inflammatory diseases and CNS diseases |
| 05/29/2007 | US7223791 Function regulator for retinoid relative receptor |
| 05/29/2007 | US7223783 Indolinone derivatives |
| 05/29/2007 | US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets |
| 05/29/2007 | US7223779 Azasugar derivative and drug containing the same as the active ingredient |
| 05/29/2007 | US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents |
| 05/29/2007 | US7223775 Stabilized ascorbic acid derivatives |
| 05/29/2007 | US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies |
| 05/29/2007 | US7223771 Inhibit the secretion of gastric acid; methyl 2,3-dimethyl-9-(2-ethyl-6-methyl-phenyl)-7H-8,9-dihydro-pyrano[2,3-c]-imidazo[1,2-a]pyridine-6-carboxylate for example; gastrointestinal inflammatory diseases such as gastric ulcers; high selectivity of action, side effect reduction, good enteral activity |
| 05/29/2007 | US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 05/29/2007 | US7223760 Substituted triazole compounds |
| 05/29/2007 | US7223758 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 05/29/2007 | US7223755 Such as (2S,5S)-5-benzyl-6-hydroxy-2-(2-methylpropyl)-3-morpholinone, which has calpain inhibitory activity; for treating cataract or retinal ischemic disorder |
| 05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 05/29/2007 | US7223741 nucleic acids containing unmethylated cytosine-guanine (CpG) dinucleotides activate lymphocytes in a subject and redirect a subject's immune response from a Th2 to a Th1 |
| 05/29/2007 | US7223738 Inhibitors of Akt activity |
| 05/29/2007 | US7223736 Composition for the prevention and treatment of cachexia |
| 05/29/2007 | US7223732 Polypeptides; wound healing agents, antiulcer agents |
| 05/29/2007 | US7223593 Anticancer agents; gene coding immunomoderator cytokine protein |
| 05/29/2007 | US7223565 for drug screening interleukins; expression in bacteria, yeast, plant, insect, and animal cells; genetic engineering |